Prepared by Putnam Insights LLC

For any early-stage bio- or med-tech company, the arrival of initial positive clinical data presents an immediate dual challenge.

First, there is the fundamental need to establish a highly credible, enduring platform for your science. To gain traction with medical opinion leaders and regulatory bodies, the data must eventually live in a respected, peer-reviewed medi...more